(Q44641122)

4 December 2017

title

Remission of refractory lupus nephritis with a protocol including rituximab (English)

1 reference

4 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1191/0961203303LU453CR

28 March 2024

author name string

G. P. Fra

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596429

28 March 2024

G. C. Avanzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596429

28 March 2024

E. Bartoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14596429

28 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14596429

28 March 2024

publication date

1 January 2003

1 reference

full work available at URL

4 December 2017

http://journals.sagepub.com/doi/pdf/10.1191/0961203303lu453cr

1 reference

https://api.crossref.org/works/10.1191/0961203303LU453CR

28 March 2024

1 reference

4 December 2017

volume

12

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

783-787

1 reference

The clinical course of the proliferative and membranous forms of lupus nephritis.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU453CR

Advances in the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU453CR

Treatment of lupus nephritis: a meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU453CR

Rituximab: mechanisms and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU453CR

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU453CR

An open study of B lymphocyte depletion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU453CR

Treatment of membranous lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU453CR

Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1191/0961203303LU453CR

Lupus nephritis: a clinical review for practicing nephrologists.

28 March 2024

4

1 reference

https://api.crossref.org/works/10.1191/0961203303LU453CR

Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group

28 March 2024

16

1 reference

https://api.crossref.org/works/10.1191/0961203303LU453CR

28 March 2024

Identifiers

1 reference

4 December 2017

1 reference